» Articles » PMID: 36609356

Direct and Indirect Effects of the COVID-19 Pandemic on Mortality in Switzerland

Overview
Journal Nat Commun
Specialty Biology
Date 2023 Jan 7
PMID 36609356
Authors
Affiliations
Soon will be listed here.
Abstract

The direct and indirect impact of the COVID-19 pandemic on population-level mortality is of concern to public health but challenging to quantify. Using data for 2011-2019, we applied Bayesian models to predict the expected number of deaths in Switzerland and compared them with laboratory-confirmed COVID-19 deaths from February 2020 to April 2022 (study period). We estimated that COVID-19-related mortality was underestimated by a factor of 0.72 (95% credible interval [CrI]: 0.46-0.78). After accounting for COVID-19 deaths, the observed mortality was -4% (95% CrI: -8 to 0) lower than expected. The deficit in mortality was concentrated in age groups 40-59 (-12%, 95%CrI: -19 to -5) and 60-69 (-8%, 95%CrI: -15 to -2). Although COVID-19 control measures may have negative effects, after subtracting COVID-19 deaths, there were fewer deaths in Switzerland during the pandemic than expected, suggesting that any negative effects of control measures were offset by the positive effects. These results have important implications for the ongoing debate about the appropriateness of COVID-19 control measures.

Citing Articles

Understanding excess mortality during COVID in Belgium: the influence of pre-existing health status and social factors.

Van den Borre L, Devleesschauwer B, Gadeyne S, Vanthomme K, Willaert D Arch Public Health. 2025; 83(1):18.

PMID: 39844284 PMC: 11756169. DOI: 10.1186/s13690-025-01499-2.


Patterns and drivers of excess mortality during the COVID-19 pandemic in 13 Western European countries.

Galmiche S, Coustaury C, Charniga K, Grant R, Cauchemez S, Fontanet A BMC Glob Public Health. 2024; 2(1):78.

PMID: 39681939 PMC: 11626765. DOI: 10.1186/s44263-024-00103-z.


Mortality associated with the COVID-19 pandemic in the Swiss dialysis population beyond SARS-CoV-2 infection.

Jaques D, Hoessly L, Guidotti R, Koller M, Ponte B, Ambuehl P Clin Kidney J. 2024; 17(12):sfae322.

PMID: 39664996 PMC: 11630737. DOI: 10.1093/ckj/sfae322.


A methodological showcase: utilizing minimal clinical parameters for early-stage mortality risk assessment in COVID-19-positive patients.

Yan J PeerJ Comput Sci. 2024; 10:e2017.

PMID: 38855224 PMC: 11157615. DOI: 10.7717/peerj-cs.2017.


Gender/Sex Disparities in the COVID-19 Cascade From Testing to Mortality: An Intersectional Analysis of Swiss Surveillance Data.

Auderset D, Amiguet M, Clair C, Riou J, Pittet V, Schwarz J Int J Public Health. 2024; 69:1607063.

PMID: 38835806 PMC: 11148283. DOI: 10.3389/ijph.2024.1607063.